Literature DB >> 34972732

Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies.

Miklos Acs1, Hubert Leebmann2, Sebastian Häusler3, Philipp Harter4, Pompiliu Piso2.   

Abstract

AIM: To present the extraperitoneal approach for the removal of peritoneal metastases in the right upper abdomen in patients with ovarian cancer and to evaluate safety and potential advantages with comparison with the traditional approach. PATIENTS AND METHODS: Detailed description of the right upper quadrant peritonectomy as extraperitoneal approach. Procedure-specific short-term complications were retrospectively analyzed in a cohort of patients.
RESULTS: Sixty-four patients were included. Full-thickness diaphragmatic resection was performed in 17% of primary cases, and in 44% of the patients with recurrent ovarian carcinoma. The rate of complete cytoreduction (CC-0) was 70%. The most common postoperative complication was pleural effusion (32%).
CONCLUSION: The extraperitoneal approach for peritonectomy of the right upper quadrant in patients with ovarian cancer is feasible, with improved access to the right subdiaphragmatic area. This enables a high rate of complete cytoreduction, and simplified and safe surgical dissection in an uncontaminated area under secured vascular structures. The early postoperative outcomes are comparable to those of the traditional transperitoneal approach.
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Extraperitoneal peritonectomy; cytoreductive surgery; ovarian cancer; upper abdomen

Mesh:

Year:  2022        PMID: 34972732      PMCID: PMC8765158          DOI: 10.21873/invivo.12708

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  41 in total

1.  Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

Authors:  S M Eisenkop; N M Spirtos
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

2.  Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer.

Authors:  Giovanni D Aletti; Sean C Dowdy; Karl C Podratz; William A Cliby
Journal:  Gynecol Oncol       Date:  2005-09-22       Impact factor: 5.482

3.  Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis.

Authors:  Hooman Soleymani Majd; Federico Ferrari; Sanjiv Manek; Kumar Gubbala; Riccardo Garruto Campanile; Kieran Hardern; Roberto Tozzi
Journal:  Gynecol Oncol       Date:  2015-12-12       Impact factor: 5.482

4.  What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

Authors:  D S Chi; E L Eisenhauer; J Lang; J Huh; L Haddad; N R Abu-Rustum; Y Sonoda; D A Levine; M Hensley; R R Barakat
Journal:  Gynecol Oncol       Date:  2006-05-22       Impact factor: 5.482

5.  The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Authors:  Oliver Zivanovic; Eric L Eisenhauer; Qin Zhou; Alexia Iasonos; Paul Sabbatini; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2007-11-13       Impact factor: 5.482

6.  Morbidity and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Data from the DGAV StuDoQ Registry with 2149 Consecutive Patients.

Authors:  Pompiliu Piso; Sebastian D Nedelcut; Beate Rau; Alfred Königsrainer; Gabriel Glockzin; Michael A Ströhlein; Rüdiger Hörbelt; Jörg Pelz
Journal:  Ann Surg Oncol       Date:  2018-11-19       Impact factor: 5.344

7.  Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

Authors:  Dennis S Chi; Corinna C Franklin; Douglas A Levine; Faina Akselrod; Paul Sabbatini; William R Jarnagin; Ronald DeMatteo; Elizabeth A Poynor; Nadeem R Abu-Rustum; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

8.  Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study.

Authors:  Myong Cheol Lim; Sokbom Kang; Jaeho Choi; Yong Jung Song; Sohee Park; Sang-Soo Seo; Sang-Yoon Park
Journal:  Ann Surg Oncol       Date:  2009-01-24       Impact factor: 5.344

9.  Diaphragmatic peritonectomy versus full thickness diaphragmatic resection and pleurectomy during cytoreduction in patients with ovarian cancer.

Authors:  P N J Pathiraja; R Garruto-Campanile; R Tozzi
Journal:  Int J Surg Oncol       Date:  2013-12-18

10.  Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.

Authors:  Shuang Ye; Tiancong He; Shanhui Liang; Xiaojun Chen; Xiaohua Wu; Huijuan Yang; Libing Xiang
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

View more
  1 in total

1.  Retrospective Analysis of Total Parietal Peritonectomy Without Systematic Lymphadenectomy for Advanced Epithelial Ovarian Cancer.

Authors:  Suguru Odajima; Hiroshi Tanabe; Yuki Koike; Kota Yokosu
Journal:  Cancer Diagn Progn       Date:  2022-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.